Efficacy of single dose recombinant herpesvirus of turkey infectious bursal disease virus (IBDV) vaccination against a variant IBDV strain

Avian Diseases

Volumn 53, Issue 4, 2009, Pages 624-628

  Perozo, F ^a   Villegas, P ^a   Fernandez, R ^b   Cruz, J ^b   Pritchard, N ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Infectious bursal disease virus; Recombinant HVT IBDV; Vaccination; Variant strains; VAXXITEK

Indexed keywords

RECOMBINANT PROTEIN; VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIRNAVIRUS INFECTION; BODY WEIGHT; BURSA FABRICII; CHICKEN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; GENETIC VARIABILITY; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; INFECTIOUS BURSAL DISEASE VIRUS; MARDIVIRUS; PATHOLOGY; VIROLOGY;

ANIMALS; ANTIGENS, VIRAL; BIRNAVIRIDAE INFECTIONS; BODY WEIGHT; BURSA OF FABRICIUS; CHICKENS; DRUG ADMINISTRATION SCHEDULE; GENETIC VARIATION; HERPESVIRUS 1, MELEAGRID; INFECTIOUS BURSAL DISEASE VIRUS; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRAL VACCINES;

AVES; GALLUS GALLUS; HERPESVIRIDAE; INFECTIOUS BURSAL DISEASE VIRUS; MELEAGRID HERPESVIRUS 1; MELEAGRIS GALLOPAVO;

EID: 73449085178     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/8687-31009RESNOTE.1     Document Type: Article

References (33)

1. Azad, A. A., M. N. Jagadish, M. A. Brown, and P. J. Hudson. Deletion mapping and expression in Escherichia coli of the large genomic segment of a birnavirus. Virology 161:145-152. 1987.
2. Banda, A., and P. Villegas. Genetic characterization of very virulent infectious bursal disease viruses from Latin America. Avian Dis. 48:540-549. 2004.
3. Bayliss, C. D., R. W. Peters, J. K. Cook, R. L. Reece, K. Howes, M. M. Binns, and M. E. Boursnell. A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. Arch. Virol. 120:193-205. 1991.
4. Bayliss, C. D., U. Spies, K. Shaw, R. W. Peters, A. Papageorgiou, H. Muller, and M. E. Boursnell. A comparison of the sequences of segment A of four infectious bursal disease virus strains and identification of a variable region in VP2. J. Gen. Virol. 71(6):1303-1312. 1990.
5. Becht, H. Infectious bursal disease virus. Curr. Top. Microbiol. Immunol. 90:107-121. 1980.
6. Birghan, C., E. Mundt, and A. E. Gorbalenya. A non-canonical lon proteinase lacking the ATPase domain employs the ser-Lys catalytic dyad to exercise broad control over the life cycle of a double-stranded RNA virus. Embo. J. 19:114-123. 2000.
7. Brandt, M., K. Yao, M. Liu, R. A. Heckert, and V. N. Vakharia. Molecular determinants of virulence, cell tropism, and pathogenic phenotype of infectious bursal disease virus. J. Virol. 75:11974-11982. 2001.
8. Bublot, M., N. Pritchard, F. X. Le Gros, and S. Goutebroze. Use of a vectored vaccine against infectious bursal disease of chickens in the face of high-titred maternally derived antibody. J. Comp. Pathol. 1:81-84. 2007.
9. Coulibaly, F., C. Chevalier, I. Gutsche, J. Pous, J. Navaza, S. Bressanelli, B. Delmas, and F. A. Rey. The birnavirus crystal structure reveals structural relationships among icosahedral viruses. Cell 120:761-772. 2005.
10. Darteil, R., M. Bublot, E. Laplace, J. F. Bouquet, J. C. Audonnet, and M. Riviere. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens. Virology 211:481-490. 1995.
11. Goutebroze, S., M. Curet, M. L. Jay, C. Roux, and F. Le Gros. Efficacy of a recombinant vaccine HVT-VP2 against Gumboro disease in the presence of maternal antibodies. Br. Poult. Sci. 44:824-825. 2003.
12. Hamoud, M. M., and P. Villegas. Identification of infectious bursal disease viruses from RNA extracted from paraffin-embedded tissue. Avian Dis. 50:476-482. 2006.
13. Hassan, M. K. Very virulent infectious bursal disease virus in Egypt: epidemiology, isolation and immunogenicity of classic vaccine. Vet. Res. Commun. 28:347-356. 2004.
14. Heine, H. G., M. Haritou, P. Failla, K. Fahey, and A. Azad. Sequence analysis and expression of the host-protective immunogen VP2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type I strains. J. Gen. Virol. 72(8):1835-1843. 1991.
15. Huang, Z., S. Elankumaran, A. S. Yunus, and S. K. Samal. A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. J. Virol. 78:10054-10063. 2004.
16. Ismail, N. M., and Y. M. Saif. Immunogenicity of infectious bursal disease viruses in chickens. Avian Dis. 35:460-469. 1991.
17. Jackwood, D. H., and Y. M. Saif. Antigenic diversity of infectious bursal disease viruses. Avian Dis. 31:766-770. 1987.
18. Letzel, T., F. Coulibaly, F. A. Rey, B. Delmas, E. Jagt, A. A. Van Loon, and E. Mundt. Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virus. J. Virol. 81:12827-12835. 2007.
19. Muller, H., M. R. Islam, and R. Raue. Research on infectious bursal disease-the past, the present and the future. Vet. Microbiol. 97:153-165. 2003.
20. Muller, H., C. Scholtissek, and H. Becht. The genome of infectious bursal disease virus consists of two segments of double-stranded RNA. J. Virol. 31:584-589. 1979.
21. Mundt, E., N. De Haas, and A. A. Van Loon. Development of a vaccine for immunization against classical as well as variant strains of infectious bursal disease virus using reverse genetics. Vaccine 21:4616-4624. 2003.
22. Perozo, F., P. Villegas, C. Estevez, I. Alvarado, and L. Purvis. A recombinant avian adeno-associated virus as a vector for infectious bursal disease vaccination. Revista Cientifica FCV/LUZ. 17:423-434. 2007.
23. Perozo, F., P. Villegas, C. Estevez, I. R. Alvarado, L. B. Purvis, and S. Williams. Protection against infectious bursal disease virulent challenge conferred by a recombinant avian adeno-associated virus vaccine. Avian Dis. 52:315-319. 2008. (Pubitemid 351883748)
24. Rosales, A. G., P. Villegas, P. D. Lukert, O. J. Fletcher, M. A. Mohamed, and J. Brown. Isolation, identification, and pathogenicity of two field strains of infectious bursal disease virus. Avian Dis. 33:35-41. 1989.
25. Rosenberger, J. K. Sentinel bird survey of Delmarva broiler flocks. In: Proc. 20th National Meeting on Poultry Health and Condemnations. Ocean City, MD. pp. 94-101. 1985.
26. Saugar, I., D. Luque, A. Ona, J. F. Rodriguez, J. L. Carrascosa, B. L. Trus, and J. R. Caston. Structural polymorphism of the major capsid protein of a double-stranded RNA virus: an amphipathic alpha helix as a molecular switch. Structure 13:1007-1017. 2005.
27. Sheppard, M., W. Werner, E. Tsatas, R. McCoy, S. Prowse, and M. Johnson. Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease. Arch. Virol. 143:915-930. 1998.
28. Snyder, D. B. Changes in the field status of infectious bursal disease virus. Avian. Pathol. 19:419-423. 1990.
29. Snyder, D. B., D. P. Lana, B. R. Cho, and W. W. Marquardt. Group and strain-specific neutralization sites of infectious bursal disease virus defined with monoclonal antibodies. Avian Dis. 32:527-534. 1988.
30. Tsukamoto, K., S. Saito, S. Saeki, T. Sato, N. Tanimura, T. Isobe, M. Mase, T. Imada, N. Yuasa, and S. Yamaguchi. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens. J. Virol. 76:5637-5645. 2002.
31. Vakharia, V. N., J. He, B. Ahamed, and D. B. Snyder. Molecular basis of antigenic variation in infectious bursal disease virus. Virus. Res. 31:265-273. 1994.
32. Winterfield, R. W., and S. B. Hitchner. Etiology of an infectious nephritis-nephrosis syndrome of chickens. Am. J. Vet. Res. 23:1273-1279. 1962.
33. Wyeth, P. J., and N. J. Chettle. Use of infectious bursal disease vaccines in chicks with maternally derived antibodies. Vet. Rec. 126:577-578. 1990.